FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2570925563> ?p ?o ?g. }

• W2570925563 endingPage "15" @default.
• W2570925563 startingPage "15" @default.
• W2570925563 abstract "Biliary cancer is a highly malignant neoplasm with poor prognosis and most patients need to undergo palliative chemotherapy, however major clinical problem associated with the use of chemotherapy is chemoresistance. So far, we aimed at investigating clinical implications of apurinic/apyrimidinic endodeoxyribonuclease 1 (APEX1) and Jagged1 as chemoresistance factors in biliary tract cancer.We used 5 human biliary tract cancer cell lines (SNU-245, SNU-308, SNU-478, SNU-1079, and SNU-1196), and investigated the chemosensitivity of APEX1 and Jagged1 through 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay and Western blot. Alternately, the 10 patients of advanced biliary cancer consist of 2 group according to the chemotherapy response examined by immunohistochemistry using APEX1 and Jagged1 antibody, and protein expression level was scored for staining intensity and percent positive cell.The result of MTT assay after APEX1 knockdown showed that strong coexpression of APEX1 and Jagged1 cell line (SNU-245, SNU-1079, and SNU-1196) showed a greater decrease in IC50 of chemotherapeutic agent (5-fluorouracil, gemcitabine and cisplatin). The Western blot analysis of APEX1 and Jagged1 expression in biliary cancer cell lines after APEX1 knockdown definitively demonstrated decreased Jagged1 expression. The APEX1 and Jagged1expression level of immunohistochemistry represented that chemorefractory patients had higher than chemoresponsive patients.These results demonstrate that simultaneous high expression of APEX1 and Jagged1 is associated with chemoresistance in biliary cancer and suggest that is a potential therapeutic target for chemoresistance in advanced biliary cancer." @default.
• W2570925563 created "2017-01-13" @default.
• W2570925563 creator A5002039698 @default.
• W2570925563 creator A5009328041 @default.
• W2570925563 creator A5014613700 @default.
• W2570925563 creator A5016539667 @default.
• W2570925563 creator A5022622397 @default.
• W2570925563 creator A5031867073 @default.
• W2570925563 creator A5042415408 @default.
• W2570925563 date "2017-01-01" @default.
• W2570925563 modified "2023-09-26" @default.
• W2570925563 title "Clinical implications of APEX1 and Jagged1 as chemoresistance factors in biliary tract cancer" @default.
• W2570925563 cites W1977168885 @default.
• W2570925563 cites W1984475127 @default.
• W2570925563 cites W1987604182 @default.
• W2570925563 cites W2002097423 @default.
• W2570925563 cites W2017467490 @default.
• W2570925563 cites W2075663237 @default.
• W2570925563 cites W2081360195 @default.
• W2570925563 cites W2101036284 @default.
• W2570925563 cites W2115261608 @default.
• W2570925563 cites W2119107697 @default.
• W2570925563 cites W2119584322 @default.
• W2570925563 cites W2120350306 @default.
• W2570925563 cites W2123767664 @default.
• W2570925563 cites W2128889451 @default.
• W2570925563 cites W2133750440 @default.
• W2570925563 cites W2139947970 @default.
• W2570925563 cites W2141078344 @default.
• W2570925563 cites W2148100870 @default.
• W2570925563 cites W4211234270 @default.
• W2570925563 doi "https://doi.org/10.4174/astr.2017.92.1.15" @default.
• W2570925563 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5234431" @default.
• W2570925563 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28090501" @default.
• W2570925563 hasPublicationYear "2017" @default.
• W2570925563 type Work @default.
• W2570925563 sameAs 2570925563 @default.
• W2570925563 citedByCount "6" @default.
• W2570925563 countsByYear W25709255632019 @default.
• W2570925563 countsByYear W25709255632020 @default.
• W2570925563 countsByYear W25709255632021 @default.
• W2570925563 countsByYear W25709255632022 @default.
• W2570925563 countsByYear W25709255632023 @default.
• W2570925563 crossrefType "journal-article" @default.
• W2570925563 hasAuthorship W2570925563A5002039698 @default.
• W2570925563 hasAuthorship W2570925563A5009328041 @default.
• W2570925563 hasAuthorship W2570925563A5014613700 @default.
• W2570925563 hasAuthorship W2570925563A5016539667 @default.
• W2570925563 hasAuthorship W2570925563A5022622397 @default.
• W2570925563 hasAuthorship W2570925563A5031867073 @default.
• W2570925563 hasAuthorship W2570925563A5042415408 @default.
• W2570925563 hasBestOaLocation W25709255632 @default.
• W2570925563 hasConcept C104317684 @default.
• W2570925563 hasConcept C121608353 @default.
• W2570925563 hasConcept C126322002 @default.
• W2570925563 hasConcept C142724271 @default.
• W2570925563 hasConcept C173396325 @default.
• W2570925563 hasConcept C203014093 @default.
• W2570925563 hasConcept C204232928 @default.
• W2570925563 hasConcept C2776415932 @default.
• W2570925563 hasConcept C2776694085 @default.
• W2570925563 hasConcept C2778239845 @default.
• W2570925563 hasConcept C2780258809 @default.
• W2570925563 hasConcept C502942594 @default.
• W2570925563 hasConcept C54355233 @default.
• W2570925563 hasConcept C55493867 @default.
• W2570925563 hasConcept C71924100 @default.
• W2570925563 hasConcept C81885089 @default.
• W2570925563 hasConcept C86803240 @default.
• W2570925563 hasConceptScore W2570925563C104317684 @default.
• W2570925563 hasConceptScore W2570925563C121608353 @default.
• W2570925563 hasConceptScore W2570925563C126322002 @default.
• W2570925563 hasConceptScore W2570925563C142724271 @default.
• W2570925563 hasConceptScore W2570925563C173396325 @default.
• W2570925563 hasConceptScore W2570925563C203014093 @default.
• W2570925563 hasConceptScore W2570925563C204232928 @default.
• W2570925563 hasConceptScore W2570925563C2776415932 @default.
• W2570925563 hasConceptScore W2570925563C2776694085 @default.
• W2570925563 hasConceptScore W2570925563C2778239845 @default.
• W2570925563 hasConceptScore W2570925563C2780258809 @default.
• W2570925563 hasConceptScore W2570925563C502942594 @default.
• W2570925563 hasConceptScore W2570925563C54355233 @default.
• W2570925563 hasConceptScore W2570925563C55493867 @default.
• W2570925563 hasConceptScore W2570925563C71924100 @default.
• W2570925563 hasConceptScore W2570925563C81885089 @default.
• W2570925563 hasConceptScore W2570925563C86803240 @default.
• W2570925563 hasIssue "1" @default.
• W2570925563 hasLocation W25709255631 @default.
• W2570925563 hasLocation W25709255632 @default.
• W2570925563 hasLocation W25709255633 @default.
• W2570925563 hasLocation W25709255634 @default.
• W2570925563 hasOpenAccess W2570925563 @default.
• W2570925563 hasPrimaryLocation W25709255631 @default.
• W2570925563 hasRelatedWork W1967786039 @default.
• W2570925563 hasRelatedWork W2021044119 @default.
• W2570925563 hasRelatedWork W2085978374 @default.
• W2570925563 hasRelatedWork W2100029565 @default.
• W2570925563 hasRelatedWork W2361287035 @default.

• next